{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:10:40Z","timestamp":1791400240211,"version":"4.3.3"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.jaut.2013.02.003","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T15:49:09Z","timestamp":1363189749000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Genetic association, seasonal infections and autoimmune basis of narcolepsy"],"prefix":"10.1016","volume":"43","author":[{"given":"Abinav Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Mahlios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2013.02.003_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.neuro.25.112701.142826","article-title":"The role of hypocretins (orexins) in sleep regulation and narcolepsy","volume":"25","author":"Taheri","year":"2002","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.jaut.2013.02.003_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/sleep\/25.1.27","article-title":"Clinical aspects of narcolepsy-cataplexy across ethnic groups","volume":"25","author":"Okun","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3810\/pgm.2009.05.2008","article-title":"Narcolepsy\u2013master of disguise: evidence-based recommendations for management","volume":"121","author":"Mohsenin","year":"2009","journal-title":"Postgraduate Medicine"},{"key":"10.1016\/j.jaut.2013.02.003_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004691-200103000-00002","article-title":"Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives","volume":"18","author":"Overeem","year":"2001","journal-title":"Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society"},{"key":"10.1016\/j.jaut.2013.02.003_bib5","first-page":"77","article-title":"Validation of a cataplexy questionnaire in 983 sleep-disorders patients","volume":"22","author":"Anic-Labat","year":"1999","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.02.003_bib7","first-page":"29","article-title":"The neurobiology of narcolepsy-cataplexy syndrome","volume":"25\u201326","author":"Aldrich","year":"1991","journal-title":"International Journal of Neurology"},{"key":"10.1016\/j.jaut.2013.02.003_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2005.03.004","article-title":"Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin\/orexin system","volume":"9","author":"Nishino","year":"2005","journal-title":"Sleep Medicine Reviews"},{"key":"10.1016\/j.jaut.2013.02.003_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s13311-012-0150-9","article-title":"A\u00a0practical guide to the therapy of narcolepsy and hypersomnia syndromes","volume":"9","author":"Mignot","year":"2012","journal-title":"Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.1016\/j.jaut.2013.02.003_bib10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","article-title":"Sodium oxybate improves excessive daytime sleepiness in narcolepsy","volume":"29","author":"Black","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","article-title":"Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial","volume":"25","author":"Hogl","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/sleep\/28.6.754","article-title":"Emerging therapies in narcolepsy-cataplexy","volume":"28","author":"Mignot","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/14728210903559852","article-title":"Emerging treatments for narcolepsy and its related disorders","volume":"15","author":"Nishino","year":"2010","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"10.1016\/j.jaut.2013.02.003_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0301-0082(93)90042-Q","article-title":"The neurobiology of narcolepsy-cataplexy","volume":"41","author":"Aldrich","year":"1993","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.jaut.2013.02.003_bib15","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.50.2_Suppl_1.S2","article-title":"Diagnostic aspects of narcolepsy","volume":"50","author":"Aldrich","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.02.003_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0301-0082(96)00070-6","article-title":"Pharmacological aspects of human and canine narcolepsy","volume":"52","author":"Nishino","year":"1997","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.jaut.2013.02.003_bib17","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin A activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Hagan","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jaut.2013.02.003_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1","article-title":"The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding","volume":"62","author":"Sutcliffe","year":"2000","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.jaut.2013.02.003_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0028-3908(00)00178-7","article-title":"Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat","volume":"40","author":"Brown","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jaut.2013.02.003_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neures.2008.01.017","article-title":"Distribution of orexins-containing fibers and contents of orexins in the rat olfactory bulb","volume":"61","author":"Shibata","year":"2008","journal-title":"Neuroscience Research"},{"key":"10.1016\/j.jaut.2013.02.003_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.sleep.2007.03.004","article-title":"Therapeutic advances in narcolepsy","volume":"8","author":"Thorpy","year":"2007","journal-title":"Sleep Medicine"},{"key":"10.1016\/j.jaut.2013.02.003_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1196\/annals.1417.026","article-title":"Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems","volume":"1129","author":"Jones","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jaut.2013.02.003_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/sleep\/1.4.413","article-title":"Genetic factors in canine narcolepsy","volume":"1","author":"Foutz","year":"1979","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2013.02.003_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.02.003_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2013.02.003_bib27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A\u00a0mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nature Medicine"},{"key":"10.1016\/j.jaut.2013.02.003_bib28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/sleep\/32.8.993","article-title":"Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy","volume":"32","author":"Thannickal","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib29","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrg1489","article-title":"Gene map of the extended human MHC","volume":"5","author":"Horton","year":"2004","journal-title":"Nature Reviews Genetics"},{"key":"10.1016\/j.jaut.2013.02.003_bib30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1399-0039.2004.00327.x","article-title":"An update of the HLA genomic region, locus information and disease associations: 2004","volume":"64","author":"Shiina","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2013.02.003_bib31","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaut.2013.02.003_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2337\/diab.22.6.429","article-title":"Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus","volume":"22","author":"Singal","year":"1973","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2013.02.003_bib33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/oxfordjournals.epirev.a018034","article-title":"HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review","volume":"22","author":"Dorman","year":"2000","journal-title":"Epidemiologic Reviews"},{"key":"10.1016\/j.jaut.2013.02.003_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0198-8859(98)00101-3","article-title":"HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis","volume":"60","author":"van der Horst-Bruinsma","year":"1999","journal-title":"Human Immunology"},{"key":"10.1016\/j.jaut.2013.02.003_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.gene.6364045","article-title":"A\u00a0review of the MHC genetics of rheumatoid arthritis","volume":"5","author":"Newton","year":"2004","journal-title":"Genes and Immunity"},{"key":"10.1016\/j.jaut.2013.02.003_bib36","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/hmg\/ddm165","article-title":"A\u00a0novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect","volume":"16","author":"Simmonds","year":"2007","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.jaut.2013.02.003_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/sleep\/9.2.371","article-title":"Fluoxetine in the treatment of cataplexy","volume":"9","author":"Langdon","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib38","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/515487","article-title":"Genetics of narcolepsy and other sleep disorders","volume":"60","author":"Mignot","year":"1997","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.jaut.2013.02.003_bib39","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/sleep\/17.suppl_8.S60","article-title":"DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib40","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1212\/WNL.48.6.1550","article-title":"HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy","volume":"48","author":"Rogers","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.02.003_bib41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.jaut.2013.02.003_bib42","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ng.647","article-title":"Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy","volume":"42","author":"Hor","year":"2010","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jaut.2013.02.003_bib43","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.02.003_bib44","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/sleep\/29.11.1429","article-title":"A\u00a0study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness","volume":"29","author":"Hong","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-5728(01)00333-2","article-title":"Narcolepsy and the HLA region","volume":"117","author":"Lin","year":"2001","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.jaut.2013.02.003_bib46","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/07853890500372047","article-title":"Genes for normal sleep and sleep disorders","volume":"37","author":"Tafti","year":"2005","journal-title":"Annals of Medicine"},{"key":"10.1016\/j.jaut.2013.02.003_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.smrv.2004.06.001","article-title":"Genetics of normal and pathological sleep in humans","volume":"9","author":"Dauvilliers","year":"2005","journal-title":"Sleep Medicine Reviews"},{"key":"10.1016\/j.jaut.2013.02.003_bib48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0140-6736(90)90842-S","article-title":"Genetic heterogeneity in narcolepsy","volume":"335","author":"Singh","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.02.003_bib49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.372","article-title":"Narcolepsy is strongly associated with the T-cell receptor alpha locus","volume":"41","author":"Hallmayer","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jaut.2013.02.003_bib50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1084\/jem.182.1.121","article-title":"T\u00a0cell receptor gene recombination patterns and mechanisms: cell death, rescue, and T cell production","volume":"182","author":"Petrie","year":"1995","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.jaut.2013.02.003_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng.734","article-title":"Common variants in P2RY11 are associated with narcolepsy","volume":"43","author":"Kornum","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1016\/j.jaut.2013.02.003_bib52","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/dds035","article-title":"Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy","volume":"21","author":"Winkelmann","year":"2012","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.jaut.2013.02.003_bib53","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.4049\/jimmunol.0803320","article-title":"Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1","volume":"182","author":"Josefowicz","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.jaut.2013.02.003_bib54","unstructured":"Faraco JLL, Kornum BR, Kenny EE, Trynka G, Einen M et\u00a0al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLOS Genetics, in press."},{"key":"10.1016\/j.jaut.2013.02.003_bib55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky's postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunology Today"},{"key":"10.1016\/j.jaut.2013.02.003_bib56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.jaut.2013.02.003_bib57","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/sleep\/32.8.979","article-title":"Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset","volume":"32","author":"Aran","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib58","doi-asserted-by":"crossref","first-page":"e9555","DOI":"10.1371\/journal.pone.0009555","article-title":"IgG abnormality in narcolepsy and idiopathic hypersomnia","volume":"5","author":"Tanaka","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2013.02.003_bib59","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","article-title":"Elevated tribbles homolog 2-specific antibody levels in narcolepsy patients","volume":"120","author":"Cvetkovic-Lopes","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.jaut.2013.02.003_bib60","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/sleep\/33.7.869","article-title":"Anti-tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy","volume":"33","author":"Kawashima","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.imlet.2005.11.010","article-title":"Regulation of expression and signalling modulator function of mammalian tribbles is cell-type specific","volume":"104","author":"Sung","year":"2006","journal-title":"Immunology Letters"},{"key":"10.1016\/j.jaut.2013.02.003_bib62","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/intimm\/dxn116","article-title":"Tribbles-2 is a novel regulator of inflammatory activation of monocytes","volume":"20","author":"Eder","year":"2008","journal-title":"International Immunology"},{"key":"10.1016\/j.jaut.2013.02.003_bib63","doi-asserted-by":"crossref","DOI":"10.1101\/gad.207654.112","article-title":"Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation","author":"Dalal","year":"2013","journal-title":"Genes and Development"},{"key":"10.1016\/j.jaut.2013.02.003_bib64","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/sleep\/33.11.1428","article-title":"Post-H1N1 narcolepsy-cataplexy","volume":"33","author":"Dauvilliers","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib65","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.biopsych.2005.04.026","article-title":"Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy","volume":"58","author":"Black","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jaut.2013.02.003_bib66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/sleep\/28.4.427","article-title":"Analysis of hypocretin (orexin) antibodies in patients with narcolepsy","volume":"28","author":"Black","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib67","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/sleep\/29.5.633","article-title":"Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy","volume":"29","author":"Tanaka","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2013.02.003_bib68","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(04)17553-3","article-title":"A\u00a0functional autoantibody in narcolepsy","volume":"364","author":"Smith","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2013.02.003_bib69","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2013.02.003_bib70","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/473436a","article-title":"Vaccines: the real issues in vaccine safety","volume":"473","author":"Kwok","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2013.02.003_bib71","series-title":"European Centre for Disease Prevention and Control (ECDC) VAESCO investigation into narcolepsy","year":"2012"},{"key":"10.1016\/j.jaut.2013.02.003_bib72","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.jaut.2013.02.003_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2012.10.030","article-title":"No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study","author":"Choe","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2013.02.003_bib74","first-page":"499","article-title":"Lymphocyte subsets in HLA-DR2-positive narcoleptic patients","volume":"39","author":"Matsuki","year":"1985","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"key":"10.1016\/j.jaut.2013.02.003_bib75","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1212\/WNL.50.4.1149","article-title":"In\u00a0vivo and in\u00a0vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls","volume":"50","author":"Hinze-Selch","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2013.02.003_bib76","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant system AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2013.02.003_bib77","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1084\/jem.180.3.1159","article-title":"Antigen-independent activation of naive and memory resting T cells by a cytokine combination","volume":"180","author":"Unutmaz","year":"1994","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.jaut.2013.02.003_bib78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.med.48.1.157","article-title":"Paraneoplastic syndromes affecting the central nervous system","volume":"48","author":"Posner","year":"1997","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.jaut.2013.02.003_bib79","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/s-2004-861540","article-title":"Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment","volume":"24","author":"Bataller","year":"2004","journal-title":"Seminars in Neurology"},{"key":"10.1016\/j.jaut.2013.02.003_bib80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/1531-8249(20010201)49:2<141::AID-ANA31>3.0.CO;2-S","article-title":"Yet another paraneoplastic antibody","volume":"49","author":"Posner","year":"2001","journal-title":"Annals of Neurology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841113000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:06:37Z","timestamp":1760256397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841113000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":80,"alternative-id":["S0896841113000358"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2013.02.003","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic association, seasonal infections and autoimmune basis of narcolepsy","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2013.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}